Experimental Oncology, 2014, № 1

ЗМІСТ

ORIGINAL CONTRIBUTIONS

Shlapatska L.M., Kovalevska L.M., Gordiienko I.M., Sidorenko S.P.
Intrinsic defect in B-lymphoblastoid cell lines from patients with X-linked lymphoproliferative disease type 1. I. Cell surface phenotype and functional studies

Hussain A., Gheewala T.M., Vas A.J., Shah K., Goala P., Khan S., Hinduja S., Sharma C.
Growth inhibitory and adjuvant therapeutic potential of aqueous extract of Triticum aestivum on MCF-7 and HeLa cells

Gerashchenko O., Zhuravel E., Skachkova O., Khranovska N., Pushkarev V., Pogrebnoy P., Soldatkina M.
Involvement of human beta-defensin-2 in regulation of malignant potential of cultured human melanoma cells

Voeykova І.М., Fedosova N.І., Karaman О.М., Yudina О.Y., Didenko G.V., Lisovenko G.S., Evstratieva L.М., Potebnya G.P.
Use of xenogeneic vaccine modified with embryonal nervous tissue antigens in the treatment of B16‑melanoma-bearing mice

Pyaskovskaya O.N., Sorokina L.V., Kolesnik D.L., Boichuk I.V., Melnikov O.R., Solyanik G.I.
Dynamics of changes of antioxidant system indexes during the growth of two Lewis lung carcinoma variants

Shevchuk Z., Filip A., Shevchuk V., Kashuba E.
Number of Langerhans cells is decreased in premalignant keratosis and skin cancers

Smorodin E.P., Sergeyev B.L., Kurtenkov O.A.
The characterization of IgG antibodies to GalNAc beta-terminated glycans of gastric cancer survivors

Soares S., Catarino R., Breda E., Medeiros R., Bravo I.
The role of nt590 P21 gene polymorphism in the susceptibility to nasopharyngeal cancer

SHORT COMMUNICATIONS

Gevorkyan L., Gambashidze K.
Anticancer efficacy of hydroxyethylthiamine diphosphate in vivo

Horacek J.M., Kupsa T., Vasatova M., Jebavy L., Zak P.
Biochip array technology and evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute myeloid leukemia

POINT OF VIEW

Cherepenko E., Telegeev G.
In search of molecular approaches to improving cancer therapy efficacy

CHRONICLE

Grigoriy Vasilievich Bondar